In this study, the phosphorylation of ERK1/2 in the normal and SSc fibroblasts was significantly enhanced by the ARα agonist, oxymetazoline, but not the ARβ agonist, isoproterenol (Fig. 3A,C). The gene discussed is MAPK3; the disease is systemic sclerosis.